NCT06335901View on ClinicalTrials.gov

Clinical Characteristics and Outcomes of Coronary Heart Disease

CompletedOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

April 30, 2022

Conditions
Coronary Heart Disease
Interventions
DRUG

Drug:Standard therapy

Percutaneous coronary Intervention

Trial Locations (1)

630000

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

All Listed Sponsors
lead

Xinjiang Medical University

OTHER

NCT06335901 - Clinical Characteristics and Outcomes of Coronary Heart Disease | Biotech Hunter | Biotech Hunter